| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.0M | -92.2% |
| R&D Expense | $175.7M | +62.8% |
| SG&A Expense | $61.0M | +9.9% |
| Operating Income | -$237.2M | -209.6% |
| Pre-tax Income | -$174.0M | -172.8% |
| Income Tax | -$27.6M | -134.3% |
| Net Income | -$146.4M | -192.4% |
| EPS (Basic) | -$0.51 | -191.1% |
| EPS (Diluted) | -$0.51 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $133.3M | -65.5% |
| Current Assets | $872.0M | -15.0% |
| Total Assets | $1.49B | -3.4% |
| Current Liabilities | $119.0M | +0.6% |
| Total Liabilities | $335.8M | +9.1% |
| Stockholders' Equity | $1.15B | -6.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.9M | -115.8% |
| Capital Expenditures | $76.9M | +8.9% |
| Investing Cash Flow | -$221.1M | +37.3% |
| Financing Cash Flow | $10.4M | +736.1% |
| Free Cash Flow | -$120.8M | -158.5% |
| -202.0% |